Pas de connexion internet — affichage de la version enregistrée de la page.

Quest Diagnostics…

USUSD
← Vers le screener
US:DGXLSE:0KSX

Quest Diagnostics Incorporated (US:DGX) — Medical Specialities. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site web
questdiagnostics.com
Relations avec les investisseurs
ir.questdiagnostics.com/overview/default.aspx
Secteur
Health Care · Medical Specialities
Siège social
Madison, United States
PDG
Steve Rusckowski
Employés
46 000
Fondée
1967
Actions en circulation
110.37 M au 2026-07-15
Flottant
109.81 M
Capitalisation boursière
25.21 Md USD
Initiés
0.43%
Investisseurs institutionnels
98.9%
Secteur d'activité (SIC)
Services-Medical Laboratories
LEI
8MCWUBXQ0WE04KMXBX50
Taux de distribution
34.2%
FCF
1.35 Md USD
27%
Dette
6.38 Md USD
3.7 ans de FCF
Ancienneté du dividende
22 ans
Bénéfices, FCF et dividendes versés — pour les 12 mois précédant 30.06.2026 (le dernier rapport de l'entreprise).
Description

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Bourses et tickers

BourseTickerDevisePrixType
US USA StocksDGX principaleUSD227.06 -0.58%actions ordinaires
LSE London Stock Exchange0KSX IOBUSD231.43 +0.00%actions ordinaires

Cours sur 3 mois

jour de hausse jour de baisse date de détachement du dividende date de versementSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Dividendes

12 derniers mois, US:DGX: 3.38 USD (4 vers.)

Quest Diagnostics Incorporated (DGX) verse des dividendes trimestriels. Au cours des 12 derniers mois, 3.38 USD par action ont été versés (versements : 4). Cela représente environ 1.49% du cours actuel de l'action. D'après l'historique des paiements, la prochaine date ex-dividende est prévue vers 05.01.2027. Historique des dividendes ininterrompu : 22 ans.

Date exVersementMontant%TypeTicker
2026-10-062026-10-210.8600 USD0.4/1.5 %trimestrielUS:DGX
2026-07-082026-07-220.8600 USD0.4/1.5 %trimestrielUS:DGX
2026-04-062026-04-200.8600 USD0.4/1.4 %trimestrielUS:DGX
2026-01-132026-01-280.8000 USD0.4/1.4 %trimestrielUS:DGX
2025-10-032025-10-200.8000 USD0.4/≈1.4 %trimestrielUS:DGX
2025-07-072025-07-210.8000 USD0.4/≈1.4 %trimestrielUS:DGX
2025-04-072025-04-210.8000 USD0.4/≈1.4 %trimestrielUS:DGX

Actualités de cette semaine

Pas encore d'actualités du site de l'entreprise.

publicité

Principaux actionnaires

DétenteurParticipationActionsDate du rapport
Blackrock Inc.8.4%9.28 M2026-06-30
Vanguard Capital Managem…6.55%7.23 M2026-06-30
Vanguard Portfolio Manag…5.55%6.13 M2026-06-30
State Street Corporation5%5.52 M2026-06-30
Price (T.Rowe) Associate…4.93%5.44 M2026-06-30
Boston Partners4.3%4.74 M2026-06-30
JPMORGAN CHASE & CO3.19%3.52 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%3.51 M2026-06-30
Geode Capital Management…2.84%3.14 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.6%2.87 M2026-06-30
Morgan Stanley2.23%2.46 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.17%2.4 M2026-06-30
Edgepoint Investment Gro…2.04%2.25 M2026-06-30
iShares Trust-iShares Co…1.33%1.47 M2026-08-31
Fidelity Concord Street…1.3%1.43 M2026-07-31
SPDR S&P 500 ETF TRUST-S…1.23%1.36 M2026-08-31
John Hancock Funds III-D…1.09%1.2 M2026-07-31
JPMorgan Trust II-JPMorg…1.04%1.15 M2026-06-30
T. Rowe Price Dividend G…1%1.11 M2026-06-30
John Hancock Funds III-D…0.96%1.06 M2026-07-31
DAVIS J E CAUSEY (Chief…≈0.13%142 4232026-03-04
DAVIS JAMES E (Chief Exe…≈0.11%122 4232026-09-01
DOHERTY CATHERINE T (Off…≈0.06%71 6242026-03-05
PREVOZNIK MICHAEL E (Gen…≈0.04%42 3372026-08-28
DEPPE MICHAEL J (Officer…≈0.03%35 1962026-03-04
SAMAD SAMER ABDUL (Chief…≈0.03%33 4782026-07-22
RING TIMOTHY M (Director…≈0.03%31 1402026-05-20
PFEIFFER GARY M (Directo…≈0.03%31 0052026-05-20
MAIN TIMOTHY L (Director…≈0.02%27 4602026-07-22
GREGG VICKY B (Director)≈0.02%18 3862026-07-22